Gottardi Enrico

Gottardi Enrico

UNVERIFIED PROFILE

Are you Gottardi Enrico?   Register this Author

Register author
Gottardi Enrico

Gottardi Enrico

Publications by authors named "Gottardi Enrico"

Are you Gottardi Enrico?   Register this Author

41Publications

765Reads

5Profile Views

Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches.

Front Oncol 2019 6;9:833. Epub 2019 Sep 6.

Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00833DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742705PMC
September 2019

Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes.

Br J Haematol 2017 02 23;176(3):491-495. Epub 2016 Feb 23.

Dipartimento di Scienze Cliniche e Biologiche, AOU San Luigi Gonzaga, Università di Torino, Orbassano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13968DOI Listing
February 2017

Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm.

Am J Hematol 2016 Sep 20;91(9):E353. Epub 2016 Jun 20.

Hematology Division, Università Degli Studi Di Torino, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24422DOI Listing
September 2016

Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor.

Clin Lymphoma Myeloma Leuk 2016 08 1;16 Suppl:S96-S100. Epub 2016 Apr 1.

Department of Clinical and Biological Sciences, University of Turin, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano (TO), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.03.008DOI Listing
August 2016

Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.

Biol Blood Marrow Transplant 2015 Oct 4;21(10):1852-5. Epub 2015 Jul 4.

Division of Hematology, Chaim Sheba Medical Center Tel Hashomer, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.06.018DOI Listing
October 2015

Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia.

Br J Haematol 2015 Jan 27;168(2):305-8. Epub 2014 Aug 27.

Haematology, Department of Cellular Biotechnologies and Haematology, "Sapienza" University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13103DOI Listing
January 2015

Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified.

J Clin Oncol 2014 Apr 21;32(10):e37-9. Epub 2014 Jan 21.

Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda-Maggiore Policlinico Hospital Foundation, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.0665DOI Listing
April 2014

Second-generation tyrosine kinase inhibitors can induce complete molecular response in Ph-positive acute lymphoblastic leukemia after allogeneic stem cell transplant.

Clin Lymphoma Myeloma Leuk 2013 Sep;13 Suppl 2:S272-5

Division of Haematology and Internal Medicine, Department of Clinical and Biological Science, University of Turin, Turin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.05.017DOI Listing
September 2013

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes.

Leuk Res 2011 Apr 23;35(4):504-7. Epub 2010 Oct 23.

Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Via Benevento 6, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.08.021DOI Listing
April 2011

Molecular monitoring in patients with chronic myelogenous leukemia.

Curr Hematol Malig Rep 2008 Apr;3(2):65-71

Department of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-008-0011-0
Publisher Site
http://dx.doi.org/10.1007/s11899-008-0011-0DOI Listing
April 2008

A multicenter evaluation of comprehensive analysis of MLL translocations and fusion gene partners in acute leukemia using the MLL FusionChip device.

Cancer Genet Cytogenet 2007 Feb;173(1):17-22

Leukaemia Research Cytogenetics Group, Cancer Sciences Division, University of Southampton, MP 822 Duthie Building, Southampton General Hospital, Southampton SO16 6YD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2006.09.006DOI Listing
February 2007

WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromes.

Methods Mol Med 2006 ;125:199-211

Department of Clinical and Biological Sciences, University of Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59745-017-0:199DOI Listing
April 2006

Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.

Haematologica 2005 Sep;90(9):1161-7

Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Azienda Ospedaliera San Luigi, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
September 2005

Myelodysplastic syndromes.

Ann N Y Acad Sci 2004 Dec;1028:400-8

Dept. of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, Gonzole 10, 10043 Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1322.048DOI Listing
December 2004